Residual cardiovascular risk test

Clonal hematopoiesis of indeterminate potential increases residual cardiovascular risk test in humans (+4.96% (p=2.07e-3)).

“The mean predicted RCVR test score was 4.96% greater at baseline for CHIP+ subjects compared to CHIP- subjects after adjusting for covariates (p=2.07e-3).”

Human trialcovariate-adjusted (treatment arm, age, sex)EDTA plasma

Using a proteomics-based test to assess cardiovascular risk in individuals with clonal hematopoiesis of indeterminate potential (CHIP)

AHA Scientific Sessions 2025 abstract·3 Nov 2025